Agarwal AK, Raja A, Brown BD (2023) Chronic Obstructive Pulmonary Disease. In: StatPearls [Internet]. StatPearls Publishing Copyright ©2024, Treasure Island (FL): StatPearls Publishing; BookshelfID: NBK559281. https://www.ncbi.nlm.nih.gov/books/NBK559281/

Chronic obstructive pulmonary disease - Christenson, S. A.; Smith, B. M.; Bafadhel, M.; Putcha, N. (Lancet, 2022)

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 - Disease, G. B. D.; Injury, I.; Prevalence, C. (Lancet, 2016)

Reactive oxygen species in chronic obstructive pulmonary disease - Boukhenouna, S.; Wilson, M. A.; Bahmed, K.; Kosmider, B. (Oxid Med Cell Longev, 2018)

Brightling C, Greening N (2019) Airway inflammation in COPD: progress to precision medicine. Eur Respir J 54(2):1900651. https://doi.org/10.1183/13993003.00651-2019

The other myeloperoxidase: emerging functions - Vanhamme, L.; Zouaoui Boudjeltia, K.; Antwerpen, P.; Delporte, C. (Arch Biochem Biophys, 2018)

Finicelli M, Digilio FA, Galderisi U, Peluso G (2022) The emerging role of macrophages in chronic obstructive pulmonary disease: the potential impact of oxidative stress and extracellular vesicle on macrophage polarization and function. Antioxidants (Basel) 11(3):464. https://doi.org/10.3390/antiox11030464

Pathological mechanism and targeted drugs of COPD - Guo, P.; Li, R.; Piao, T. H.; Wang, C. L.; Wu, X. L.; Cai, H. Y. (Int J Chron Obstruct Pulmon Dis, 2022)

Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases - Russell, R. E.; Thorley, A.; Culpitt, S. V.; Dodd, S.; Donnelly, L. E.; Demattos, C.; Fitzgerald, M.; Barnes, P. J. (Am J Physiol Lung Cell Mol Physiol, 2002)

Matrix metalloproteinase expression by human alveolar macrophages in relation to emphysema - Wallace, A. M.; Sandford, A. J.; English, J. C.; Burkett, K. M.; Li, H.; Finley, R. J.; Muller, N. L.; Coxson, H. O.; Pare, P. D.; Abboud, R. T. (COPD, 2008)

Matrix metalloproteinases in emphysema - Gharib, S. A.; Manicone, A. M.; Parks, W. C. (Matrix Biol, 2018)

Nuclear factor-kappa B and its role in inflammatory lung disease - Alharbi, K. S.; Fuloria, N. K.; Fuloria, S.; Rahman, S. B.; Al-Malki, W. H.; Javed Shaikh, M. A.; Thangavelu, L.; Singh, S. K.; Rama Raju Allam, V. S.; Jha, N. K. (Chem Biol Interact, 2021)

Pathogenesis of COPD at the cellular and molecular level - DIS, A.; Gnemmi, I.; Dossena, F.; Ricciardolo, F. L.; Maniscalco, M.; Lo Bello, F.; Balbi, B. (Minerva Med, 2022)

Cigarette smoke extract induces pyroptosis in human bronchial epithelial cells through the ROS/NLRP3/caspase-1 pathway - Zhang, M. Y.; Jiang, Y. X.; Yang, Y. C.; Liu, J. Y.; Huo, C.; Ji, X. L.; Qu, Y. Q. (Life Sci, 2021)

New drugs under development for COPD - Uwagboe, I.; Adcock, I. M.; Lo Bello, F.; Caramori, G.; Mumby, S. (Minerva Med, 2022)

Emerging pharmaceutical therapies for COPD - Lakshmi, S. P.; Reddy, A. T.; Reddy, R. C. (Int J Chron Obstruct Pulmon Dis, 2017)

Macrophage polarization involved the inflammation of chronic obstructive pulmonary disease by S1P/HDAC1 signaling - Zhang, M.; Hei, R.; Zhou, Z.; Xiao, W.; Liu, X.; Chen, Y. (Am J Cancer Res, 2023)

HDAC5 RNA interference ameliorates acute renal injury by upregulating KLF2 and inhibiting NALP3 expression in a mouse model of oxalate nephropathy - Sharma, P.; Karnam, K.; Mahale, A.; Sedmaki, K.; Krishna Venuganti, V.; Kulkarni, O. P. (Int Immunopharmacol, 2022)

Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-kappaB-mediated inflammation - Leus, N. G.; Zwinderman, M. R.; Dekker, F. J. (Curr Opin Chem Biol, 2016)

HDAC5 promotes Mycoplasma pneumoniae-induced inflammation in macrophages through NF-kappaB activation - Zhao, Y.; Ma, G.; Yang, X. (Life Sci, 2019)

Histone deacetylase 5 regulates the inflammatory response of macrophages - Poralla, L.; Stroh, T.; Erben, U.; Sittig, M.; Liebig, S.; Siegmund, B.; Glauben, R. (J Cell Mol Med, 2015)

HDAC5 promotes intestinal sepsis via the Ghrelin/E2F1/NF-kappaB axis - Li, B.; Zhang, L.; Zhu, L.; Cao, Y.; Dou, Z.; Yu, Q. (FASEB J, 2021)

Semaglutide ameliorates lipopolysaccharide-induced acute lung injury through inhibiting HDAC5-mediated activation of NF-kappaB signaling pathway - Jiang, Z.; Tan, J.; Yuan, Y.; Shen, J.; Chen, Y. (Hum Exp Toxicol, 2022)

Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1beta release - Bockstiegel, J.; Wurnig, S. L.; Engelhardt, J.; Enns, J.; Hansen, F. K.; Weindl, G. (Biochem Pharmacol, 2023)

HDAC6 inhibition attenuates renal injury by reducing IL-1beta secretion and RIP kinase mediated necroptosis in acute oxalate nephropathy - Sedmaki, K.; Karnam, K.; Sharma, P.; Mahale, A.; Routholla, G.; Ghosh, B.; Prakash Kulkarni, O. (Int Immunopharmacol, 2022)

Therapeutic effects of histone deacetylase inhibitors in a murine asthma model - Ren, Y.; Su, X.; Kong, L.; Li, M.; Zhao, X.; Yu, N.; Kang, J. (Inflamm Res, 2016)

Tryptophan co-metabolism at the host-pathogen interface - Costantini, C.; Bellet, M. M.; Renga, G.; Stincardini, C.; Borghi, M.; Pariano, M.; Cellini, B.; Keller, N.; Romani, L.; Zelante, T. (Front Immunol, 2020)

Regulation of host physiology and immunity by microbial indole-3-aldehyde - Zelante, T.; Puccetti, M.; Giovagnoli, S.; Romani, L. (Curr Opin Immunol, 2021)

Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22 - Zelante, T.; Iannitti, R. G.; Cunha, C.; Luca, A.; Giovannini, G.; Pieraccini, G.; Zecchi, R.; D’Angelo, C.; Massi-Benedetti, C.; Fallarino, F. (Immunity, 2013)

Liu M, Wang Y, Xiang H, Guo M, Li S, Liu M, Yao J (2023) The tryptophan metabolite indole-3-carboxaldehyde alleviates mice with DSS-induced ulcerative colitis by balancing amino acid metabolism, inhibiting intestinal inflammation, and improving intestinal barrier function. Molecules 28(9):3704. https://doi.org/10.3390/molecules28093704

Indole-3-aldehyde reduces inflammatory responses and restores intestinal epithelial barrier function partially via Aryl Hydrocarbon Receptor (AhR) in experimental colitis models - Wang, M.; Guo, J.; Hart, A. L.; Li, J. V. (J Inflamm Res, 2023)

A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor - Yu, J.; Luo, Y.; Zhu, Z.; Zhou, Y.; Sun, L.; Gao, J.; Sun, J.; Wang, G.; Yao, X.; Li, W. (J Allergy Clin Immunol, 2019)

Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor - Rothhammer, V.; Mascanfroni, I. D.; Bunse, L.; Takenaka, M. C.; Kenison, J. E.; Mayo, L.; Chao, C. C.; Patel, B.; Yan, R.; Blain, M. (Nat Med, 2016)

Gut microbe-derived metabolite indole-3-carboxaldehyde alleviates atherosclerosis - Lu, Y.; Yang, W.; Qi, Z.; Gao, R.; Tong, J.; Gao, T.; Zhang, Y.; Sun, A.; Zhang, S.; Ge, J. (Signal Transduct Target Ther, 2023)

Development and in vitro-in vivo performances of an inhalable indole-3-carboxaldehyde dry powder to target pulmonary inflammation and infection - Puccetti, M.; Gomes Dos Reis, L.; Pariano, M.; Costantini, C.; Renga, G.; Ricci, M.; Traini, D.; Giovagnoli, S. (Int J Pharm, 2021)

Targeting the aryl hydrocarbon receptor with indole-3-aldehyde protects from vulvovaginal candidiasis via the IL-22-IL-18 cross-talk - Borghi, M.; Pariano, M.; Solito, V.; Puccetti, M.; Bellet, M. M.; Stincardini, C.; Renga, G.; Vacca, C.; Sellitto, F.; Mosci, P. (Front Immunol, 2019)

Enteric formulated indole-3-carboxaldehyde targets the aryl hydrocarbon receptor for protection in a murine model of metabolic syndrome - Puccetti, M.; Pariano, M.; Borghi, M.; Barola, C.; Moretti, S.; Galarini, R.; Mosci, P.; Ricci, M.; Costantini, C.; Giovagnoli, S. (Int J Pharm, 2021)

Comparison between cigarette smoke-induced emphysema and cigarette smoke extract-induced emphysema - He, Z. H.; Chen, P.; Chen, Y.; He, S. D.; Ye, J. R.; Zhang, H. L.; Cao, J. (Tob Induc Dis, 2015)

Increased exploration and hyperlocomotion in a cigarette smoke and LPS-induced murine model of COPD: linking pulmonary and systemic inflammation with the brain - Pelgrim, C. E.; Wang, L.; Peralta Marzal, L. N.; Korver, S.; Ark, I.; Leusink-Muis, T.; Braber, S.; Folkerts, G.; Garssen, J.; Helvoort, A. (Am J Physiol Lung Cell Mol Physiol, 2022)

The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation - Hoffmann, A.; Levchenko, A.; Scott, M. L.; Baltimore, D. (Science, 2002)

HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases - Shanmugam, G.; Rakshit, S.; Sarkar, K. (Transl Oncol, 2022)

Identifying gut microbes that affect human health - Leviatan, S.; Segal, E. (Nature, 2020)

Exploring gut microbes in human health and disease: Pushing the envelope - Sun, J.; Chang, E. B. (Genes Dis, 2014)

The impact of the gut microbiome on extra-intestinal autoimmune diseases - Miyauchi, E.; Shimokawa, C.; Steimle, A.; Desai, M. S.; Ohno, H. (Nat Rev Immunol, 2023)

The path toward using microbial metabolites as therapies - Descamps, H. C.; Herrmann, B.; Wiredu, D.; Thaiss, C. A. (EBioMedicine, 2019)

Puccetti M, Xiroudaki S, Ricci M, Giovagnoli S (2020) Postbiotic-enabled targeting of the host-microbiota-pathogen interface: Hints of antibiotic decline? Pharmaceutics 12(7):624. https://doi.org/10.3390/pharmaceutics12070624

Zolkiewicz J, Marzec A, Ruszczynski M, Feleszko W (2020) Postbiotics-a step beyond pre- and probiotics. Nutrients 12(8):2189. https://doi.org/10.3390/nu12082189

The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics - Salminen, S.; Collado, M. C.; Endo, A.; Hill, C.; Lebeer, S.; Quigley, E. M. M.; Sanders, M. E.; Shamir, R.; Swann, J. R.; Szajewska, H. (Nat Rev Gastroenterol Hepatol, 2021)

Regulation of inflammation by short chain fatty acids - Vinolo, M. A.; Rodrigues, H. G.; Nachbar, R. T.; Curi, R. (Nutrients, 2011)

Short-chain fatty acids improve inflamm-aging and acute lung injury in old mice - Hildebrand, C. B.; Lichatz, R.; Pich, A.; Muhlfeld, C.; Woltemate, S.; Vital, M.; Brandenberger, C. (Am J Physiol Lung Cell Mol Physiol, 2023)

Acetate, a gut bacterial product, ameliorates ischemia-reperfusion induced acute lung injury in rats - Hung, K. Y.; Wu, S. Y.; Pao, H. P.; Liao, W. I.; Chu, S. J. (Int Immunopharmacol, 2022)

Indole-3-aldehyde alleviates chondrocytes inflammation through the AhR-NF-κB signalling pathway - Zhuang, H.; Li, B.; Xie, T.; Xu, C.; Ren, X.; Jiang, F.; Lei, T.; Zhou, P. (Int Immunopharmacol, 2022)

Huang SS, Liu R, Chang S, Li X, Weng X, Ge J (2023) Gut microbiota-derived tryptophan metabolite indole-3-aldehyde ameliorates aortic dissection. Nutrients 15(19):4150. https://doi.org/10.3390/nu15194150

Activation of aryl hydrocarbon receptor in Langerhans cells by a microbial metabolite of tryptophan negatively regulates skin inflammation - Liu, X.; Zhang, X.; Zhang, J.; Luo, Y.; Xu, B.; Ling, S.; Zhang, Y.; Li, W.; Yao, X. (J Dermatol Sci, 2020)

Puccetti M, Pariano M, Renga G, Santarelli I, D'Onofrio F, Bellet MM, Stincardini C, Bartoli A, Costantini C, Romani L et al (2021) Targeted drug delivery technologies potentiate the overall therapeutic efficacy of an indole derivative in a mouse cystic fibrosis setting. Cells 10(7):1601. https://doi.org/10.3390/cells10071601

Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases - Gueders, M. M.; Foidart, J. M.; Noel, A.; Cataldo, D. D. (Eur J Pharmacol, 2006)

Role of Oxidative Stress and Genetic Polymorphism of Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 in COPD - Sangwan, P.; Quasimi, H.; Sharma, J. G.; Habib, M. A.; Alam, M. I. (Chronic Obstr Pulm Dis, 2023)

Elevated serum matrix metalloprotease (MMP-2) as a candidate biomarker for stable COPD - Mahor, D.; Kumari, V.; Vashisht, K.; Galgalekar, R.; Samarth, R. M.; Mishra, P. K.; Banerjee, N.; Dixit, R.; Saluja, R.; De, S. (BMC Pulm Med, 2020)

Elevated MMP-12 protein levels in induced sputum from patients with COPD - Demedts, I. K.; Morel-Montero, A.; Lebecque, S.; Pacheco, Y.; Cataldo, D.; Joos, G. F.; Pauwels, R. A.; Brusselle, G. G. (Thorax, 2006)

Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice - Hautamaki, R. D.; Kobayashi, D. K.; Senior, R. M.; Shapiro, S. D. (Science, 1997)

NF-kappaB signaling in chronic inflammatory airway disease - Schuliga, M. (Biomolecules, 2015)

Mechanisms of oxidative stress effects of the NADPH oxidase-ROS-NF-kappaB transduction pathway and VPO1 on patients with chronic obstructive pulmonary disease combined with pulmonary hypertension - Zhuan, B.; Yu, Y.; Yang, Z.; Zhao, X.; Li, P. (Eur Rev Med Pharmacol Sci, 2017)

Dysregulated apoptosis and NFkappaB expression in COPD subjects - Brown, V.; Elborn, J. S.; Bradley, J.; Ennis, M. (Respir Res, 2009)

The Notch ligand DNER regulates macrophage IFNgamma release in chronic obstructive pulmonary disease - Ballester-Lopez, C.; Conlon, T. M.; Ertuz, Z.; Greiffo, F. R.; Irmler, M.; Verleden, S. E.; Beckers, J.; Fernandez, I. E.; Eickelberg, O.; Yildirim, A. O. (EBioMedicine, 2019)

Histone deacetylase 5 deacetylates the phosphatase PP2A for positively regulating NF-kappaB signaling - Xu, C.; Tang, J.; Yang, Q.; Zhao, H.; Liu, Y.; Cao, J.; Zhou, Y.; Chen, X.; Chen, J. (J Biol Chem, 2021)

Overexpression of HDAC6 induces pro-inflammatory responses by regulating ROS-MAPK-NF-kappaB/AP-1 signaling pathways in macrophages - Youn, G. S.; Lee, K. W.; Choi, S. Y.; Park, J. (Free Radic Biol Med, 2016)

The role of the NLRP3 inflammasome in chronic inflammation in asthma and chronic obstructive pulmonary disease - Wu, Y.; Di, X.; Zhao, M.; Li, H.; Bai, L.; Wang, K. (Immun Inflamm Dis, 2022)

The NLRP3 inflammasome: activation and regulation - Xu, J.; Nunez, G. (Trends Biochem Sci, 2023)

Roles of TRPA1 and TRPV1 in cigarette smoke -induced airway epithelial cell injury model - Wang, M.; Zhang, Y.; Xu, M.; Zhang, H.; Chen, Y.; Chung, K. F.; Adcock, I. M.; Li, F. (Free Radic Biol Med, 2019)

Cigarette smoke and extracellular Hsp70 induce secretion of ATP and differential activation of NLRP3 inflammasome in monocytic and bronchial epithelial cells - Rumora, L.; Somborac-Bacura, A.; Hlapcic, I.; Hulina-Tomaskovic, A.; Rajkovic, M. G. (Cytokine, 2020)

NLRP3 inflammasome-a key player in antiviral responses - Zhao, C.; Zhao, W. (Front Immunol, 2020)

Pathogenic NLRP3 inflammasome activity during Candida infection is negatively regulated by IL-22 via activation of NLRC4 and IL-1Ra - Borghi, M.; Luca, A.; Puccetti, M.; Jaeger, M.; Mencacci, A.; Oikonomou, V.; Pariano, M.; Garlanda, C.; Moretti, S.; Bartoli, A. (Cell Host Microbe, 2015)

Targeting HDAC6 attenuates nicotine-induced macrophage pyroptosis via NF-kappaB/NLRP3 pathway - Xu, S.; Chen, H.; Ni, H.; Dai, Q. (Atherosclerosis, 2021)

Pharmacological inhibition of HDAC6 attenuates NLRP3 inflammatory response and protects dopaminergic neurons in experimental models of Parkinson’s disease - Yan, S.; Wei, X.; Jian, W.; Qin, Y.; Liu, J.; Zhu, S.; Jiang, F.; Lou, H.; Zhang, B. (Front Aging Neurosci, 2020)

Histone deacetylases (HDACs): characterization of the classical HDAC family - Ruijter, A. J.; Gennip, A. H.; Caron, H. N.; Kemp, S.; Kuilenburg, A. B. (Biochem J, 2003)

Erasers of histone acetylation: the histone deacetylase enzymes - Seto, E.; Yoshida, M. (Cold Spring Harb Perspect Biol, 2014)

Immunomodulatory role of nutrients: how can pulmonary dysfunctions improve? - Gozzi-Silva, S. C.; Teixeira, F. M. E.; Duarte, A.; Sato, M. N.; Oliveira, L. M. (Front Nutr, 2021)

HDAC inhibition regulates oxidative stress in CD4(+)Thelper cells of chronic obstructive pulmonary disease and non-small cell lung cancer patients via mitochondrial transcription factor a (mtTFA) modulating NF-kappaB/HIF1alpha axis - Shanmugam, G.; Subramaniyam, K.; George, M.; Sarkar, K. (Int Immunopharmacol, 2023)

Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease - Barnes, P. J. (J Allergy Clin Immunol, 2013)

Decreased histone deacetylase activity in chronic obstructive pulmonary disease - Ito, K.; Ito, M.; Elliott, W. M.; Cosio, B.; Caramori, G.; Kon, O. M.; Barczyk, A.; Hayashi, S.; Adcock, I. M.; Hogg, J. C. (N Engl J Med, 2005)

SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease - Rajendrasozhan, S.; Yang, S. R.; Kinnula, V. L.; Rahman, I. (Am J Respir Crit Care Med, 2008)

HDAC1–3 inhibitor MS-275 enhances IL10 expression in RAW264.7 macrophages and reduces cigarette smoke-induced airway inflammation in mice - Leus, N. G.; Bosch, T.; Wouden, P. E.; Krist, K.; Ourailidou, M. E.; Eleftheriadis, N.; Kistemaker, L. E.; Bos, S.; Gjaltema, R. A.; Mekonnen, S. A. (Sci Rep, 2017)

HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-kappaB p65 transcriptional activity - Leus, N. G.; Wouden, P. E.; Bosch, T.; Hooghiemstra, W. T. R.; Ourailidou, M. E.; Kistemaker, L. E.; Bischoff, R.; Gosens, R.; Haisma, H. J.; Dekker, F. J. (Biochem Pharmacol, 2016)

Histone deacetylase 6 modulates macrophage infiltration during inflammation - Yan, B.; Xie, S.; Liu, Y.; Liu, W.; Li, D.; Liu, M.; Luo, H. R.; Zhou, J. (Theranostics, 2018)

Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility - Waltregny, D.; Glenisson, W.; Tran, S. L.; North, B. J.; Verdin, E.; Colige, A.; Castronovo, V. (FASEB J, 2005)

HDAC6 inhibitor Cay10603 inhibits high glucose-induced oxidative stress, inflammation and apoptosis in retinal pigment epithelial cells via regulating NF-kappaB and NLRP3 inflammasome pathway - Yang, Q.; Li, S.; Zhou, Z.; Fu, M.; Yang, X.; Hao, K.; Liu, Y. (Gen Physiol Biophys, 2020)

Histone deacetylase 6 negatively regulates NLRP3 inflammasome activation - Hwang, I.; Lee, E.; Jeon, S. A.; Yu, J. W. (Biochem Biophys Res Commun, 2015)

Porphyromonas gingivalis infection promotes inflammation via inhibition of the AhR signalling pathway in periodontitis - Hao, T.; Zhang, R.; Zhao, T.; Wu, J.; Leung, W. K.; Yang, J.; Sun, W. (Cell Prolif, 2023)

Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease - Swimm, A.; Giver, C. R.; DeFilipp, Z.; Rangaraju, S.; Sharma, A.; Ulezko Antonova, A.; Sonowal, R.; Capaldo, C.; Powell, D.; Qayed, M. (Blood, 2018)

Chronic aryl hydrocarbon receptor activity impairs muscle mitochondrial function with tobacco smoking - Fitzgerald, L. F.; Lackey, J.; Moussa, A.; Shah, S. V.; Castellanos, A. M.; Khan, S.; Schonk, M.; Thome, T.; Salyers, Z. R.; Jakkidi, N. (J Cachexia Sarcopenia Muscle, 2024)

Indoles from the commensal microbiota act via the AHR and IL-10 to tune the cellular composition of the colonic epithelium during aging - Powell, D. N.; Swimm, A.; Sonowal, R.; Bretin, A.; Gewirtz, A. T.; Jones, R. M.; Kalman, D. (Proc Natl Acad Sci USA, 2020)

Ozone-induced aryl hydrocarbon receptor activation controls lung inflammation via interleukin-22 modulation - Michaudel, C.; Bataille, F.; Maillet, I.; Fauconnier, L.; Colas, C.; Sokol, H.; Straube, M.; Couturier-Maillard, A.; Dumoutier, L.; Snick, J. (Front Immunol, 2020)

Aryl hydrocarbon receptor: A bridge linking immuno-inflammation and metabolism in atherosclerosis - Li, K.; Li, K.; He, Y.; Liang, S.; Shui, X.; Lei, W. (Biochem Pharmacol, 2023)